伯氨喹啉(以下简称伯喹)是目前根治间日疟的有效药场,但在剂量与疗程上一直是争论与探讨的问题。为此,我们于1982年7月～1983年6月,在淮安县季桥乡采用伯喹120mg 合并氯喹1.5g,对间日疟现症患进行治疗,同时用氯喹作对照,各治疗114例,兹将治疗结果报告如下。一、病例选择与分组凡现症间日疟经血检确诊、临床发作不超过3次,年龄在10～55岁之间、半月内未服过抗疟药者,按病人就诊 Primary aminoquinoline (hereinafter referred to as primary quinoline) is currently an effective cure for Plasmodium vivax, but the dose and duration of treatment has been a controversial issue. To this end, we July 1982 ~ June 1983, in Qiaqiao Township, Huai’an County, the use of primaquine 120mg combined with chloroquine 1.5g, vivax malaria is treated, while using chloroquine as a control, the treatment of 114 cases The treatment results are reported below. First, the case selection and grouping Where the disease is diagnosed with vivax malaria, clinical attack no more than 3 times, aged 10 to 55 years old, did not take anti-malaria drugs within half a month, according to the patient treatment